Armistice Capital »

First Wave Biopharma shares owned by Armistice Capital

Quarter-by-quarter ownership of First Wave Biopharma (ENTO) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in First Wave Biopharma

Tip: Access up to 7 years of quarterly data

All positions including First Wave Biopharma held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Wave Biopharma by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $155k 126k 1.23
2024-03-31 $118k 27k 4.38

More positions owned by Armistice Capital

Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Incyte Corporation (INCY)
Immunovant (IMVT)
Travere Therapeutics (TVTX)
Agios Pharmaceuticals (AGIO)
Grifols S A Sp Adr Rep B Nvt (GRFS)
Argenx Se Sponsored Adr (ARGX)
Inari Medical Ord (NARI)
Anheuser Busch Inbev Sa Sponsored Adr (BUD)
Dentsply Sirona (XRAY)
Novo-nordisk A S Adr (NVO)

View all positions for Armistice Capital

Top funds holding First Wave Biopharma

Virtu Financial
Two Sigma Securities
Geode Capital Management
Citadel Advisors
Tower Research Capital
FMR
Bank of America Corporation
UBS Group
Us Bancorp

View all funds holding First Wave Biopharma